Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- 15 May 2015
- journal article
- research article
- Published by Elsevier BV in Lancet
- Vol. 385 (9981), 1949-1956
- https://doi.org/10.1016/S0140-6736(14)62220-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology studyWorld Journal of Urology, 2013
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United StatesClinical Infectious Diseases, 2012
- Fluoroquinolone Resistance Among Gram-Negative Urinary Tract Patho-gens: Global Smart Program Results, 2009-2010The Open Microbiology Journal, 2012
- Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritisJournal of Infection, 2010
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure InfectionClinical Infectious Diseases, 2010
- Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and PyelonephritisAntimicrobial Agents and Chemotherapy, 2009
- Therapeutic challenges of urosepsisEuropean Journal of Clinical Investigation, 2008
- A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute PyelonephritisUrology, 2008
- Ertapenem versus Cefotetan Prophylaxis in Elective Colorectal SurgeryThe New England Journal of Medicine, 2006
- Testing for Interaction in Studies of NoninferiorityJournal of Biopharmaceutical Statistics, 2003